Literature DB >> 24085616

The mechanisms linking adiposopathy to type 2 diabetes.

Jichun Yang1, Jihong Kang, Youfei Guan.   

Abstract

Obesity is defined as excessive accumulation of body fat in proportion to body size. When obesity occurs, the functions of adipose tissue may be deregulated, which is termed as adiposopathy. Adiposopathy is an independent risk factor for many diseases, including diabetes and cardiovascular diseases. In overweight or obese subjects with adiposopathy, hyperlipidemia exerts lipotoxicity in pancreatic islet and liver and induces pancreatic β cell dysfunction and liver insulin resistance, which are the decisive factors causing type 2 diabetes. Moreover, adipokines have been shown to play important roles in the regulation of glucose homeostasis. When adiposopathy occurs, abnormal changes in the serum adipokine profile correlate with the development and progression of pancreatic β cell dysfunction and insulin resistance in peripheral tissue. The current paper briefly discusses the latest findings regarding the effects of adiposopathy-related lipotoxicity and cytokine toxicity on the development of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085616     DOI: 10.1007/s11684-013-0288-9

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  125 in total

1.  [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].

Authors:  Anna Romanowska; Dariusz Marek Lebensztejn
Journal:  Pol Merkur Lekarski       Date:  2010-06

Review 2.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

3.  Plasma interleukin-1β concentrations are closely associated with fasting blood glucose levels in healthy and preclinical middle-aged nonoverweight and overweight Japanese men.

Authors:  Yasumi Misaki; Rie Miyauchi; Kazuki Mochizuki; Satsuki Takabe; Masaya Shimada; Yoko Ichikawa; Toshinao Goda
Journal:  Metabolism       Date:  2010-02-19       Impact factor: 8.694

4.  Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.

Authors:  Matthew C Ernst; Mark Issa; Kerry B Goralski; Christopher J Sinal
Journal:  Endocrinology       Date:  2010-03-12       Impact factor: 4.736

5.  FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways.

Authors:  Ping Jiao; Jie Ma; Bin Feng; Hao Zhang; J Alan Diehl; Y Eugene Chin; Weiqun Yan; Haiyan Xu
Journal:  Obesity (Silver Spring)       Date:  2010-09-09       Impact factor: 5.002

6.  Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

Authors:  J M Chan; E B Rimm; G A Colditz; M J Stampfer; W C Willett
Journal:  Diabetes Care       Date:  1994-09       Impact factor: 19.112

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  Resistin is expressed in pancreatic islets.

Authors:  Alexandra H Minn; Noelle B Patterson; Stephanie Pack; Steven C Hoffmann; Oksana Gavrilova; Charles Vinson; David M Harlan; Anath Shalev
Journal:  Biochem Biophys Res Commun       Date:  2003-10-17       Impact factor: 3.575

9.  Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress.

Authors:  Ilham Kharroubi; Laurence Ladrière; Alessandra K Cardozo; Zeynep Dogusan; Miriam Cnop; Décio L Eizirik
Journal:  Endocrinology       Date:  2004-08-05       Impact factor: 4.736

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  9 in total

Review 1.  Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox.

Authors:  Harold Bays
Journal:  Curr Atheroscler Rep       Date:  2014-05       Impact factor: 5.113

Review 2.  Oxidative stress in obesity: a critical component in human diseases.

Authors:  Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Antonio Nicotera; Eleonora Parisi; Gabriella Di Rosa; Eloisa Gitto; Teresa Arrigo
Journal:  Int J Mol Sci       Date:  2014-12-26       Impact factor: 5.923

3.  High L-Valine Concentrations Associate with Increased Oxidative Stress and Newly-Diagnosed Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Authors:  Wen Hu; Panpan Yang; Zhenzhen Fu; Yongqing Wang; Ying Zhou; Zhengqin Ye; Yingyun Gong; Aijie Huang; Luning Sun; Yang Zhao; Tao Yang; Zhong Li; Xian-Cheng Jiang; Weinan Yu; Hongwen Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-19       Impact factor: 3.168

4.  Impaired β cell function in Chinese newly diagnosed type 2 diabetes mellitus with hyperlipidemia.

Authors:  Yuhang Ma; Yufan Wang; Qianfang Huang; Qian Ren; Su Chen; Aifang Zhang; Li Zhao; Qin Zhen; Yongde Peng
Journal:  J Diabetes Res       Date:  2014-04-14       Impact factor: 4.011

5.  Expression of CTRP3, a novel adipokine, in rats at different pathogenic stages of type 2 diabetes mellitus and the impacts of GLP-1 receptor agonist on it.

Authors:  Xin Li; Li Jiang; Miao Yang; Yu-wen Wu; Su-xin Sun; Jia-zhong Sun
Journal:  J Diabetes Res       Date:  2014-08-11       Impact factor: 4.011

Review 6.  Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction.

Authors:  Harold Bays
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

Review 7.  Epicardial Fat: Physiological, Pathological, and Therapeutic Implications.

Authors:  Juan Salazar; Eliana Luzardo; José Carlos Mejías; Joselyn Rojas; Antonio Ferreira; José Ramón Rivas-Ríos; Valmore Bermúdez
Journal:  Cardiol Res Pract       Date:  2016-04-26       Impact factor: 1.866

8.  FAM3A enhances adipogenesis of 3T3-L1 preadipocytes via activation of ATP-P2 receptor-Akt signaling pathway.

Authors:  Yujing Chi; Jing Li; Na Li; Zhenzhen Chen; Liping Ma; Weikang Peng; Xiuying Pan; Mei Li; Weidong Yu; Xiangjun He; Bin Geng; Qinghua Cui; Yulan Liu; Jichun Yang
Journal:  Oncotarget       Date:  2017-07-11

9.  Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice.

Authors:  Eun-Young Kwon; Myung-Sook Choi
Journal:  Nutrients       Date:  2018-10-03       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.